OLD AND NEW EMERGING THEREPIES FOR MULTIPLE SCLEROSIS 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 10

Abstract

Multiple sclerosis (MS) is an autoimmune disease that is characterized by central nervous system inflammation, demyelination, and axon loss. It’s affect up to two million people world wide and represents a prime cause of neurological disability in young adults and has wide health, psychological, economical and social consequences. Experimental autoimmune encephalomyelitis (EAE), an animal model of human MS, is a demyelinating, inflammatory disease of the CNS and is induced by the immunization of susceptible strains of rats or mice with myelin antigens combined with adjuvant. The current treatments for MS progression include disease modifying agent viz. cytostatic, immunomodulatory drugs such as mitoxantrone and cyclophosphamide (CY), biological agents such as interferon (IFN)-beta, natalizumab and the random polymer glatiramer acetate. Although clear-cut beneficial effects are observed in many patients treated with these drugs, in addition, all of these compounds have potentially serious side effects, some require systemic administration and the biological agents are costly and immunogenic, causing response failure during prolonged treatment. The present review compiled the data on those agents which shows promising affect in different clinical trial of MS and its animal model EAE and therefore used in treatment of MS in future.  

Authors and Affiliations

Akanksha Kulshreshtha, Hansraj Manda

Keywords

Related Articles

NEUROPHARMACOLOGICAL EXPLORATION OF THUJA OCCIDENTALIS LINN. 

In present study, oral administration of 100, 200 and 400 mg/kg doses of the aqueous extract of Thuja occidentalis Linn in rats and mice were evaluated for its anxiolytic, nootropic, anticonvulsant and motor coordination...

SEMISOLID DOSAGE FORM OF PHENYTOIN SODIUM 

Phenytoin sodium was formulated in a solid dosage form using different bases; o/w emulsion base, water soluble base, oleaginous base, and vanishing cream base. Bases were prepared in two different concentrations, 5% and...

PHYTOCHEMICAL SCREENING, CYTOTOXIC AND HYPOGLYCEMIC ACTIVITY OF METHANOLIC EXTRACT OF CITRUS SINENSIS PEEL  

Orange has been traditionally used as an adjuvant in different diseases including diabetes, tuberculosis, asthma and hypertension. An examination of the impacts of peel extract from Citrus sinensis in hyperglycemic Albin...

STUDY OF KRIMIGHNA EFFECT OF NIMBA (AZADIRACTA INDICA A.JUSS.) PATRA AS RAKSHOGHNA DHOOPAN BY CULTURE AND SENSITIVITY METHOD W.S.R. TO PYOGENIC BACTERIA 

Nimbapatra (Azadiracta indica A.juss) is described as Krimighna in Ayurvedic literature. In the present study Pyogenic bacteria i.e. Staphylococcus aureus and Streptococcus pyogenus were grown on artificial media in labo...

SCAFFOLD: TISSUE ENGINEERING AND REGENERATIVE MEDICINE 

Scaffolds are the central components, which are used to deliver the cells, drug and gene into the body. Polymeric scaffolds may be prepared as typical 3-D porous matrix, nanofibrous matrix, thermo sensitive sol-gel trans...

Download PDF file
  • EP ID EP140656
  • DOI -
  • Views 99
  • Downloads 0

How To Cite

Akanksha Kulshreshtha, Hansraj Manda (2012). OLD AND NEW EMERGING THEREPIES FOR MULTIPLE SCLEROSIS . International Research Journal of Pharmacy (IRJP), 3(10), 53-60. https://europub.co.uk/articles/-A-140656